v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net (loss) $ (1,981,127) $ (7,963,076)
Adjustments to reconcile net loss to net cash (used in) operations:    
Share-based compensation 828,197 5,285,690
Change in derivative liability (755,950) 1,319,366
Debt discount for warrants 17,998
Gain on the forgiveness of debt (1,545,211)
Warrants issued for financing fee 167,704
Gain on the extinguishment of debt (233,991)
Common stock issued as a financing fee 491,441
Cryptocurrency 185,986
Amortization of note discount 211,333
Change in operating assets and liabilities:    
Accounts payable and accrued expenses 1,219,990 526,474
Net cash (used in) operating activities (1,411,627) (813,546)
Cash flows from financing activities:    
Payment of notes payable (629)
Proceeds from the issuance of convertible notes 1,010,780
Proceeds from issuance of notes payable 496,918 742,339
Net cash provided by financing activities 1,507,069 742,339
Net increase (decrease) in cash and cash equivalents 95,442 (71,207)
Cash and cash equivalents at the beginning of the period 1,763 72,970
Cash and cash equivalents at the end of the period 97,205 1,763
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Common stock issued to reduce convertible debt 1,702,020 2,823,314
Common stock issued to reduce accrued liabilities $ 711,000